Evidence map›Paper›PMID 15572672›Full record

ArticleMolecular and cellular biology2004

Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage.

Fabrizio Thorel, Angelos Constantinou, Isabelle Dunand-Sauthier, Thierry Nouspikel, Philippe Lalle, Anja Raams, Nicolaas G J Jaspers, Wim Vermeulen, Mahmud K K Shivji, Richard D Wood and 1 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. XPG: a multitasking genome caretaker.Cellular and molecular life sciences : CMLS · 2022
    Review
  8. Mechanism of action of nucleotide excision repair machinery.Biochemical Society transactions · 2022
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Clinical utility gene card for: Xeroderma pigmentosum.European journal of human genetics : EJHG · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 5 countries.

Fabrizio ThorelDepartment of Microbiology and Molecular Medicine, University Medical Centre, 1 rue Michel-Servet, 1211 Geneva 4, Switzerland.
Angelos Constantinou
Isabelle Dunand-Sauthier
Thierry Nouspikel
Philippe Lalle
Anja Raams
Nicolaas G J Jaspers
Wim Vermeulen
Mahmud K K Shivji
Richard D Wood
Stuart G Clarkson
Institute of Molecular Medicine · INCancer Research UK · GBUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

XPG is the human endonuclease that cuts 3' to DNA lesions during nucleotide excision repair. Missense mutations in XPG can lead to xeroderma pigmentosum (XP), whereas truncated or unstable XPG proteins cause Cockayne syndrome (CS), normally yielding life spans of <7 years. One XP-G individual who had advanced XP/CS symptoms at 28 years has been identified. The genetic, biochemical, and cellular defects in this remarkable case provide insight into the onset of XP and CS, and they reveal a previously unrecognized property of XPG. Both of this individual's XPG alleles produce a severely truncated protein, but an infrequent alternative splice generates an XPG protein lacking seven internal amino acids, which can account for his very slight cellular UV resistance. Deletion of XPG amino acids 225 to 231 does not abolish structure-specific endonuclease activity. Instead, this region is essential for interaction with TFIIH and for the stable recruitment of XPG to sites of local UV damage after the prior recruitment of TFIIH. These results define a new functional domain of XPG, and they demonstrate that recruitment of DNA repair proteins to sites of damage does not necessarily lead to productive repair reactions. This observation has potential implications that extend beyond nucleotide excision repair.

Indexed as

Ultraviolet RaysAlternative SplicingAmino Acid SequenceCell LineCell Line, TransformedCell Transformation, ViralDNA-Binding ProteinsDNA DamageDNA Excision Repair Protein ERCC-5DNA Mutational AnalysisDNA RepairEndonucleasesFibroblastsFluorescent Antibody Technique, IndirectFrameshift MutationHumansDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5EndonucleasesNuclear ProteinsRecombinant ProteinsTranscription FactorsTranscription Factors, TFIITranscription Factor TFIIH

Identifiers

PMID15572672
PMCPMC533987
OpenAlexW2153872103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.